Skip to content
Politically.com Search all
Menu

Final rule 2026-12165

Medical Devices; Gastroenterology-Urology Devices; Classification of the Ingestible Gastrointestinal Blood Detection Capsule

The Food and Drug Administration (FDA) is classifying the ingestible gastrointestinal blood detection capsule into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the ingestible gastrointestinal blood detection capsule. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of safety and effectiveness of the device. We believe this action will also enhance patients' access to beneficial innovative devices, in part by reducing regulatory burdens.

Source: FederalRegister.gov API v1Recently refreshed. Last successful refresh: 2026-07-31 22:49:02 UTC.

Source-supplied record

Document details

Document number
2026-12165
Published
Jun 17, 2026
Effective
Jun 17, 2026
Comments close
Not supplied
Federal Register citation
91 FR 36520

Docket identifiers

  • Docket No. FDA-2026-N-6536

CFR references

  • Title 21, part 876